De novo design and preparation of Copper(II)–based chemotherapeutic anticancer drug candidates with Boc–glycine and N,N–donor ligands: DNA binding, cleavage profile, and cytotoxic therapeutic response against MCF–7, PC–3, and HCT

De novo design and preparation of Copper(II)–based chemotherapeutic anticancer drug candidates with Boc–glycine and N,N–donor ligands: DNA binding, cleavage profile, and cytotoxic therapeutic response against MCF–7, PC–3, and HCT–116 cells

Published:2024-09 Issue: Volume:259 Page:117064
ISSN:0277-5387
Container-title:Polyhedron
language:en
Short-container-title:Polyhedron

Author:

Akhter Suffora,Kaur Gursimar,Arjmand Farukh,Tabassum Sartaj

Funder

University Grants Commission

Department of Chemistry, Aligarh Muslim University

Sophisticated Analytical Instrument Facility

Chandigarh University

Publisher

Elsevier BV

Reference55 articles.

1. Copper—A “Modern” Bioelement;Kaim;Angew. Chemie Int. Ed. English.,1996

2. Targeting copper in cancer therapy: “Copper That Cancer”;Denoyer;Metallomics,2015

3. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents;Gou;Eur. J. Med. Chem.,2017

4. Study on potential antitumor mechanism of a novel Schiff Base copper(II) complex: Synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity;Qiao;J. Inorg. Biochem.,2011

5. Mononuclear copper(II) complexes with 2-thiophene carboxylate and N-N donors; DNA interaction, antioxidant/anti-inflammatory and antitumor activity;Boulsourani;Mater. Sci. Eng. C,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Z-scheme heterojunction g-C3N4/GO/CuFe2O4 (CGC) nanocomposite: Enhanced photocatalytic, antibacterial and anticancer properties;Journal of Molecular Structure;2024-08